Teleflex has parted ways with CEO Liam Kelly and is putting a retired board member in charge of the company on an interim basis. The company, which disclosed the changes Thursday, framed the changes ...

On August 3, 2026, Teleflex completed the previously announced sale of its Original Equipment Manufacturing and Development Services business to an affiliate of Montagu and Kohlberg for $1.5 billion ...

Combining leading in-house expertise with platform-enhancing investments to accelerate advances in engineering, innovation and manufacturing ...

Teleflex quarterly update covers Russell 1000 healthcare operations, medical device products, hospital technologies, global ...

Explore Teleflex FDA-approved plasma platform, healthcare operations, trauma care technologies, product developments, and S&P ...

Teleflex (TFX) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $3.73 per share a year ago. These figures are ...

Medical technology company Teleflex (NYSE:TFX) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 28.9% year on year to $570.3 million. Its non-GAAP profit of $1.76 ...

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity ...

Key Points Interested in Teleflex Incorporated? Here are five stocks we like better. Teleflex exceeded Q2 expectations, with revenue of $570.3 million, adjusted EPS of $1.76 and strong growth in ...

Teleflex Incorporated has announced a contract with Vizient, Inc. for the supply of its Central Venous Access Catheters and Arterial Catheters, effective January 1, 2025. Vizient, the largest provider ...

Teleflex may be enjoying improved profits and sales. But it will still lay off workers and close plants as it restructures in the face of what top executive Benson F. Smith describes as "continuing ...